UCLH is the first site to recruit a patient to a national urgent public health study analysing viral genomic data in real time to reduce the spread of Covid-19 in hospitals.
Researchers have identified an immune response detectable in the blood of patients with Covid-19 that could be used to determine whether a patient with the virus will develop severe lung complications.
UCLH will be part of a first-of-its kind clinical trial, led by scientists at UCL, that will evaluate the use of ‘real time’ viral genomic data to reduce the spread of COVID-19 within hospitals.
A feature in The Lancet Respiratory Medicine has shone a spotlight on the experience of the UCLH and UCL team that worked with Mercedes F1 engineers to develop a life-saving breathing aid at the height of the pandemic.
A study supported by the NIHR UCLH Biomedical Research Centre carried out at UCL has found that people who have experienced post-traumatic stress disorder (PTSD) are up to twice as likely to develop dementia later in life.
UCLH clinicians and researchers have launched a new ‘tele-otology’ service – the first of its kind in the UK that allows ENT surgeons to assess patients’ hearing and ear problems remotely and shorten treatment pathways.
UCL and UCLH researchers have published the first health economic model able to identify cost-effective innovative hearing loss treatments that can be adopted into hearing care.
